Quality requirements for stereotactic body radiation therapy (SBRT) in multi-institutional clinical trials

Y. Xiao; F. Yin; Feng Ming Kong; J. Yue; J. Galvin

doi:10.1007/978-3-642-29305-4_599

Quality requirements for stereotactic body radiation therapy (SBRT) in multi-institutional clinical trials

Y. Xiao, F. Yin, Feng Ming Kong, J. Yue, J. Galvin

Radiation Oncology

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

Abstract

Clinical evidence have shown SBRT to be a tolerable, efficacious, and promising non-invasive therapy. Randomized prospective studies comparing surgery vs. SBRT in early-stage lung cancer are proposed to further investigate the relative survival, quality of life, and cost characteristics of these treatment paradigms. Accreditation and dosimetry requirements were carefully vetted for RTOG SBRT trials. Advanced technologies introduced since have posed additional challenges. This study provides an overview of the quality requirements including those for the recently introduced technologies.

Original language	English (US)
Title of host publication	World Congress on Medical Physics and Biomedical Engineering
Pages	2284-2287
Number of pages	4
DOIs	https://doi.org/10.1007/978-3-642-29305-4_599
Publication status	Published - Apr 16 2013
Event	World Congress on Medical Physics and Biomedical Engineering - Beijing, China Duration: May 26 2012 → May 31 2012

Publication series

Name	IFMBE Proceedings
Volume	39 IFMBE
ISSN (Print)	1680-0737

Other

Other	World Congress on Medical Physics and Biomedical Engineering
Country	China
City	Beijing
Period	5/26/12 → 5/31/12

Fingerprint

Keywords

NSCLC
SBRT
Surgery
clinical trials
quality

ASJC Scopus subject areas

Bioengineering
Biomedical Engineering

Cite this

Xiao, Y., Yin, F., Kong, F. M., Yue, J., & Galvin, J. (2013). Quality requirements for stereotactic body radiation therapy (SBRT) in multi-institutional clinical trials. In World Congress on Medical Physics and Biomedical Engineering (pp. 2284-2287). (IFMBE Proceedings; Vol. 39 IFMBE). https://doi.org/10.1007/978-3-642-29305-4_599

Quality requirements for stereotactic body radiation therapy (SBRT) in multi-institutional clinical trials. / Xiao, Y.; Yin, F.; Kong, Feng Ming; Yue, J.; Galvin, J.

World Congress on Medical Physics and Biomedical Engineering. 2013. p. 2284-2287 (IFMBE Proceedings; Vol. 39 IFMBE).

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

Xiao, Y, Yin, F, Kong, FM, Yue, J & Galvin, J 2013, Quality requirements for stereotactic body radiation therapy (SBRT) in multi-institutional clinical trials. in World Congress on Medical Physics and Biomedical Engineering. IFMBE Proceedings, vol. 39 IFMBE, pp. 2284-2287, World Congress on Medical Physics and Biomedical Engineering, Beijing, China, 5/26/12. https://doi.org/10.1007/978-3-642-29305-4_599

@inproceedings{6a47a0a8b55b4a779b9505f48abda5c3,

title = "Quality requirements for stereotactic body radiation therapy (SBRT) in multi-institutional clinical trials",

abstract = "Clinical evidence have shown SBRT to be a tolerable, efficacious, and promising non-invasive therapy. Randomized prospective studies comparing surgery vs. SBRT in early-stage lung cancer are proposed to further investigate the relative survival, quality of life, and cost characteristics of these treatment paradigms. Accreditation and dosimetry requirements were carefully vetted for RTOG SBRT trials. Advanced technologies introduced since have posed additional challenges. This study provides an overview of the quality requirements including those for the recently introduced technologies.",

keywords = "NSCLC, SBRT, Surgery, clinical trials, quality",

author = "Y. Xiao and F. Yin and Kong, {Feng Ming} and J. Yue and J. Galvin",

year = "2013",

month = "4",

day = "16",

doi = "10.1007/978-3-642-29305-4_599",

language = "English (US)",

isbn = "9783642293047",

series = "IFMBE Proceedings",

pages = "2284--2287",

booktitle = "World Congress on Medical Physics and Biomedical Engineering",

note = "World Congress on Medical Physics and Biomedical Engineering ; Conference date: 26-05-2012 Through 31-05-2012",

}

TY - GEN

T1 - Quality requirements for stereotactic body radiation therapy (SBRT) in multi-institutional clinical trials

AU - Xiao, Y.

AU - Yin, F.

AU - Kong, Feng Ming

AU - Yue, J.

AU - Galvin, J.

PY - 2013/4/16

Y1 - 2013/4/16

N2 - Clinical evidence have shown SBRT to be a tolerable, efficacious, and promising non-invasive therapy. Randomized prospective studies comparing surgery vs. SBRT in early-stage lung cancer are proposed to further investigate the relative survival, quality of life, and cost characteristics of these treatment paradigms. Accreditation and dosimetry requirements were carefully vetted for RTOG SBRT trials. Advanced technologies introduced since have posed additional challenges. This study provides an overview of the quality requirements including those for the recently introduced technologies.

AB - Clinical evidence have shown SBRT to be a tolerable, efficacious, and promising non-invasive therapy. Randomized prospective studies comparing surgery vs. SBRT in early-stage lung cancer are proposed to further investigate the relative survival, quality of life, and cost characteristics of these treatment paradigms. Accreditation and dosimetry requirements were carefully vetted for RTOG SBRT trials. Advanced technologies introduced since have posed additional challenges. This study provides an overview of the quality requirements including those for the recently introduced technologies.

KW - NSCLC

KW - SBRT

KW - Surgery

KW - clinical trials

KW - quality

UR - http://www.scopus.com/inward/record.url?scp=84876020076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876020076&partnerID=8YFLogxK

U2 - 10.1007/978-3-642-29305-4_599

DO - 10.1007/978-3-642-29305-4_599

M3 - Conference contribution

AN - SCOPUS:84876020076

SN - 9783642293047

T3 - IFMBE Proceedings

SP - 2284

EP - 2287

BT - World Congress on Medical Physics and Biomedical Engineering

T2 - World Congress on Medical Physics and Biomedical Engineering

Y2 - 26 May 2012 through 31 May 2012

ER -

Access to Document

10.1007/978-3-642-29305-4_599